FORT MYERS, Fla., June 03, 2024 (GLOBE NEWSWIRE) -- American Oncology Network (AON) (Nasdaq: AONC), one of the nation’s fastest-growing community oncology networks, today announced the appointment of David Afshar as chief financial and operating officer. “We are pleased to welcome Dave to AON and the leadership team,” said Todd Schonherz, AON’s chief executive officer. “Over his impressive tenure in healthcare, Dave has built a strong track record, and his expertise in both finance and operations makes him ...

FORT MYERS, Fla., May 21, 2024 (GLOBE NEWSWIRE) -- American Oncology Network ("AON" or the "Company") (NASDAQ:AONC), a rapidly growing network of community-based oncology practices, announced today its decision to voluntarily delist its Class A common stock and warrants from The Nasdaq Capital Market ("Nasdaq"). The Company's decision to delist its securities from Nasdaq was recommended to the Board of Directors (the "Board") of the Company by a Special Committee (the "Special Committee") of the Board compr ...

FORT MYERS, Fla., May 16, 2024 (GLOBE NEWSWIRE) -- American Oncology Network (AON) (NASDAQ:AONC), one of the nation's fastest-growing networks of community oncology practices, is pleased to announce the appointment of William "Bill" J. Valle to its Board of Directors, effective April 19, 2024. "On behalf of the Board, I am honored to be officially welcoming Bill," said Stephen "Fred" Divers, MD, AON's chief medical officer and vice chairman of the Board. "Bill has extensive experience and knowledge that wil ...

FORT MYERS, Fla., May 16, 2024 (GLOBE NEWSWIRE) -- American Oncology Network (AON) (Nasdaq: AONC), one of the nation’s fastest-growing networks of community oncology practices, is pleased to announce the appointment of William “Bill” J. Valle to its Board of Directors, effective April 19, 2024. “On behalf of the Board, I am honored to be officially welcoming Bill,” said Stephen “Fred” Divers, MD, AON’s chief medical officer and vice chairman of the Board. “Bill has extensive experience and knowledge that wi ...

财务数据和关键指标变化 - 第一季度收入为3.643亿美元,同比增长20% [23] - 成本增加7640万美元至3.549亿美元,主要由于患者就诊量增加和单次就诊成本上升 [24][25] - 税前亏损2490万美元,上年同期亏损150万美元 [26] - 调整后EBITDA为200万美元,上年同期为400万美元,下降200万美元 [26] - 总流动性为1.327亿美元,包括7490万美元现金和3010万美元短期有价证券 [27] 各条业务线数据和关键指标变化 - 公司未具体披露各业务线的数据和指标变化 [无] 各个市场数据和关键指标变化 - 公司在得克萨斯州和马里兰州的现有市场完成了两家医疗机构的收购 [9][12] - 公司还宣布在夏威夷和佐治亚州进行战略性扩张 [13] 公司战略和发展方向及行业竞争 - 公司继续执行增长计划,完成两家医疗机构的收购,并宣布另外两家的收购 [9] - 公司的差异化服务包括内部提供专科药房、实验室等临床服务,以及集中的运营和技术平台 [10][11][14] - 公司推出了"Meaningful Insights Biotech Analytics"平台,利用人工智能技术优化和个性化医疗方案 [15][16] - 公司自2018年成立以来,已发展成为拥有240多名医生、覆盖21个州的全国性肿瘤医疗平台 [18][19] 管理层对经营环境和未来前景的评论 - 公司在2023年实现了近13亿美元的收入,并保持了良好的发展势头 [18] - 公司将继续推动增长、提高效率,并执行丰富的机会管道 [19] - 公司的差异化服务和整合平台有助于吸引更多医疗机构加入 [10][11][14] - 新推出的人工智能平台有望进一步支持公司的附属服务和临床平台的扩展 [15][16] 问答环节重要的提问和回答 无

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 001-04321 American Oncology Network, Inc. (Exact name of registrant as specified in its charter) Delaware 85-3984427 (State or other jurisdiction of incorporat ...

Exhibit 99.1 American Oncology Network, Inc. Announces First Quarter 2024 Financial Results First Quarter 2024 Highlights • Revenue of $364.3 million increased by 20.0% compared to the prior year quarter o Patient encounter growth of 7.1% as compared to the prior year quarter • Added 17 new providers to the AON platform o Expanded in Texas and Maryland markets FORT MYERS, Fla., May 15, 2024 – American Oncology Network, Inc. (NASDAQ: AONC), a leading oncology platform with an innovative model of physician-le ...

FORT MYERS, Fla., May 15, 2024 (GLOBE NEWSWIRE) -- American Oncology Network (AON) (NASDAQ:AONC), one of the nation's fastest-growing community oncology networks, and the AON Central Lab are pleased to announce the implementation of the new cytogenetics A.I. software HiBand v8.4 for karyogram segmentation and classification. AON Central Lab is the first laboratory in the world to utilize this technology.   Cytogenetics A.I. leverages machine learning to screen chromosomes and genetic disorders in real time ...

FORT MYERS, Fla., May 14, 2024 (GLOBE NEWSWIRE) -- American Oncology Network ("AON" or the "Company") (NASDAQ:AONC), one of the fastest growing community-based oncology practices, announced today that the Company will change the release date of its first quarter 2024 financial results to Monday, May 20, 2024, prior to market open. The Company will host a conference call and live webcast with the investment community at 8:30 a.m. Eastern Time the following day. To access the call through a conference line, d ...

FORT MYERS, Fla., May 14, 2024 (GLOBE NEWSWIRE) -- American Oncology Network (“AON” or the “Company”) (Nasdaq: AONC), one of the fastest growing community-based oncology practices, announced today that the Company will change the release date of its first quarter 2024 financial results to Monday, May 20, 2024, prior to market open. The Company will host a conference call and live webcast with the investment community at 8:30 a.m. Eastern Time the following day. To access the call through a conference line, ...